Orgenesis Inc. (ORGS)
Sector: Biotechnology
Industry: Biotechnology
Orgenesis Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 0.3000 | 0.3300 | 0.3000 | 0.3300 | 1,262 |
| Nov 13, 2026 | 0.3750 | 0.3750 | 0.3750 | 0.3750 | 110 |
| Nov 12, 2026 | 0.3000 | 0.3000 | 0.3000 | 0.3000 | 100 |
| Nov 11, 2026 | 0.3456 | 0.3456 | 0.3000 | 0.3000 | 429 |
| Nov 10, 2026 | 0.3000 | 0.3000 | 0.3000 | 0.3000 | 100 |
| Nov 9, 2026 | 0.3500 | 0.3500 | 0.3500 | 0.3500 | 100 |
| Nov 6, 2026 | 0.3500 | 0.3500 | 0.3500 | 0.3500 | 100 |
| Nov 5, 2026 | 0.4900 | 0.4900 | 0.4000 | 0.4000 | 900 |
| Nov 4, 2026 | 0.4900 | 0.4900 | 0.4900 | 0.4900 | 100 |
| Nov 2, 2026 | 0.0467 | 0.0467 | 0.0467 | 0.0467 | 104 |
| Oct 30, 2026 | 0.0500 | 0.4000 | 0.0280 | 0.0280 | 6,300 |
| Oct 27, 2026 | 0.0467 | 0.3250 | 0.0467 | 0.0467 | 2,611 |
| Oct 22, 2026 | 0.0467 | 0.4000 | 0.0467 | 0.4000 | 5,100 |
| Oct 15, 2026 | 0.0567 | 0.0567 | 0.0567 | 0.0567 | 2,524 |
| Oct 13, 2026 | 0.0700 | 0.0700 | 0.0700 | 0.0700 | 17,615 |
| Oct 6, 2026 | 0.3500 | 0.3500 | 0.3500 | 0.3500 | 200 |
| Oct 5, 2026 | 0.5500 | 0.5500 | 0.5500 | 0.5500 | 100 |
| Oct 2, 2026 | 0.0667 | 0.5800 | 0.0667 | 0.5800 | 357 |
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Director | Grant/Award | 1.8K | -- | Dec 12, 2024 | |
| Director | Grant/Award | 1.3K | -- | Dec 12, 2024 | |
| Director | Grant/Award | 625 | -- | Dec 12, 2024 | |
| Director | Grant/Award | 1.5K | -- | Dec 12, 2024 | |
| Director | Grant/Award | 1.3K | -- | Dec 12, 2024 | |
| Director | Grant/Award | 625 | -- | Dec 12, 2024 |
| Name | Shares | % | Source |
|---|---|---|---|
Neurocords LLC · may incl. warrants· filed Mar 2025 | 1.2M | 23.2% | 13G |
JACOB SAFIER · may incl. warrants· filed Dec 2024 | 51.6K | 1.0% | 13G |
Knoll Capital Management, LLC | 50.6K | 1.0% | 13F |
Insiders
- Nanda AshishDirector
- BHALAJI JAGANNATHANDirector
- Vider ItzhakDirector
- NAGARAJ SANTHOSHDirector
- Adler YaronDirector
- PELAVIN ADAMDirector
- Safier Jacob10% Owner
Top institutional holders
Orgenesis Inc. is a global biotechnology firm dedicated to the field of cell and gene therapies.
The company has engineered an innovative Point of Care (POCare) platform. This system incorporates a portfolio of licensed POCare therapeutics, which are manufactured and prepared using automated, self-contained POCare technology within a cooperative network. Orgenesis primarily concentrates on autologous therapies, developing customized processes and systems for each treatment. These utilize a closed, automated processing methodology, validated for safe and compliant production directly at the patient's location, facilitating immediate therapeutic application. Established in 2008 as Business Outsourcing Service, Inc., the company adopted the name Orgenesis Inc. in August 2011 and is headquartered in Germantown, Maryland.
based on 5.17M shares outstanding
30d Avg
1.79K
60d Avg
1.66K
90d Avg
1.37K
Orgenesis Inc. (OTC: ORGS) traded at $0.3300 on Nov 16, 2026, down 12.00% from the previous close of $0.3750. 52-week range: $0.0001 to $0.8450. The company is in the Healthcare sector (Biotechnology).